ITMI911953A0 - Procedimento di preparazione di composizione a cessione protratta e le composizioni cosi' ottenute - Google Patents

Procedimento di preparazione di composizione a cessione protratta e le composizioni cosi' ottenute

Info

Publication number
ITMI911953A0
ITMI911953A0 IT91MI1953A ITMI911953A ITMI911953A0 IT MI911953 A0 ITMI911953 A0 IT MI911953A0 IT 91MI1953 A IT91MI1953 A IT 91MI1953A IT MI911953 A ITMI911953 A IT MI911953A IT MI911953 A0 ITMI911953 A0 IT MI911953A0
Authority
IT
Italy
Prior art keywords
protractive
compositions
procedure
preparation
transfer composition
Prior art date
Application number
IT91MI1953A
Other languages
English (en)
Inventor
Jean-Mare Ruiz
Original Assignee
Sod Conseils Rech Applic
Conseil De Rech Etd Applic Sci
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic, Conseil De Rech Etd Applic Sci filed Critical Sod Conseils Rech Applic
Publication of ITMI911953A0 publication Critical patent/ITMI911953A0/it
Publication of ITMI911953A1 publication Critical patent/ITMI911953A1/it
Application granted granted Critical
Publication of IT1251788B publication Critical patent/IT1251788B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Glanulating (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITMI911953A 1990-08-01 1991-07-15 Procedimento di preparazione di composizione a cessione protratta e le composizioni cosi' ottenute IT1251788B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions

Publications (3)

Publication Number Publication Date
ITMI911953A0 true ITMI911953A0 (it) 1991-07-15
ITMI911953A1 ITMI911953A1 (it) 1993-01-15
IT1251788B IT1251788B (it) 1995-05-26

Family

ID=10679993

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI911953A IT1251788B (it) 1990-08-01 1991-07-15 Procedimento di preparazione di composizione a cessione protratta e le composizioni cosi' ottenute

Country Status (30)

Country Link
US (1) US5213812A (it)
JP (1) JP2818704B2 (it)
KR (1) KR920003962A (it)
AT (1) AT396425B (it)
AU (2) AU649696B2 (it)
BE (1) BE1004772A3 (it)
CA (1) CA2048270C (it)
CH (1) CH682715A5 (it)
DE (1) DE4125542A1 (it)
DK (1) DK175756B1 (it)
ES (1) ES2046083B1 (it)
FI (1) FI104149B (it)
FR (1) FR2665360B1 (it)
GB (1) GB9016885D0 (it)
GR (1) GR1001512B (it)
HK (1) HK33294A (it)
IE (1) IE65124B1 (it)
IN (1) IN178446B (it)
IT (1) IT1251788B (it)
LU (1) LU87982A1 (it)
MA (1) MA22245A1 (it)
MY (1) MY107500A (it)
NL (1) NL194637C (it)
NO (1) NO300158B1 (it)
NZ (1) NZ238981A (it)
OA (1) OA09387A (it)
PT (1) PT98497B (it)
SE (1) SE505734C2 (it)
TN (1) TNSN91067A1 (it)
ZA (1) ZA915565B (it)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
US5569467A (en) * 1993-05-15 1996-10-29 Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) Process for the preparation of microballs and microballs thus obtained
CA2184242C (en) * 1994-02-28 2000-05-02 Jorg Kreuter Drug targeting system, method for preparing same and its use
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
AU4571097A (en) * 1996-10-09 1998-05-05 Takeda Chemical Industries Ltd. A method for producing a microparticle
MY118835A (en) * 1997-04-18 2005-01-31 Ipsen Pharma Biotech Sustained release compositions and the process for their preparation
WO1999052708A1 (en) 1998-04-13 1999-10-21 Luminex Corporation Liquid labeling with fluorescent microparticles
ES2245128T3 (es) * 1998-12-16 2005-12-16 Aventis Pharmaceuticals Inc. Antagonista del receptor de serotonina encapsulado en polimero biodegradable y metodo para su preparacion.
AU5644400A (en) * 1999-09-24 2001-03-29 Rohm And Haas Company Pellet compositions
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
DE60138641D1 (de) 2000-10-27 2009-06-18 Baxter Healthcare Sa Herstellung von mikrokügelchen
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
ES2307779T3 (es) * 2001-08-16 2008-12-01 Baxter International Inc. Formulaciones de microparticulas a base de propelentes.
FR2848113B1 (fr) * 2002-12-04 2005-02-25 Oreal Stabilisation de principes actifs aromatiques par des polymeres aromatiques
US20040166077A1 (en) * 2002-12-04 2004-08-26 L'oreal Process for treating keratin materials with aromatic active principles
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
SG135204A1 (en) * 2003-07-18 2007-09-28 Baxter Int Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
EP1646354A4 (en) * 2003-07-22 2010-03-17 Baxter Int SMALL SPHERICAL PARTICLES OF LOW MOLECULAR WEIGHT MOLECULES AND PROCESSES FOR THEIR PREPARATION AND USE
US20060135277A1 (en) * 2003-09-10 2006-06-22 Marnocha Bendict F Golf club and practice arrangement
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
CN103393601A (zh) * 2004-05-12 2013-11-20 巴克斯特国际公司 含有蛋白并在高浓度蛋白下显示可注射性的微球体
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
CN103432079A (zh) * 2004-05-12 2013-12-11 巴克斯特国际公司 含有寡核苷酸的微球体及其在制备用于治疗1型糖尿病的药物中的应用
MXPA06012990A (es) 2004-05-12 2007-02-12 Baxter Int Microesferas de acidos nucleicos, produccion y suministro de las mismas.
AU2005271781A1 (en) * 2004-07-13 2006-02-16 Altairnano, Inc. Ceramic structures for prevention of drug diversion
CA2573344A1 (en) * 2004-07-13 2006-02-16 Altairnano, Inc. Ceramic structures for controlled release of drugs
JP2008528443A (ja) * 2004-10-29 2008-07-31 アドヒーシブズ・リサーチ・インコーポレイテッド セキュリティ・アイデンティフィケーションのための微視的なタグ付けシステム
MX2007013356A (es) * 2005-04-27 2008-03-26 Baxter Int Microparticulas modificadas en la superficie y metodos de formacion y uso de las mismas.
AU2006283170A1 (en) * 2005-08-23 2007-03-01 Altairnano, Inc. Highly photocatalytic phosphorus-doped anatase-TiO2 composition and related manufacturing methods
WO2007103824A1 (en) * 2006-03-02 2007-09-13 Altairnano, Inc. Nanostructured metal oxides
US20080038482A1 (en) * 2006-03-02 2008-02-14 Fred Ratel Method for Low Temperature Production of Nano-Structured Iron Oxide Coatings
WO2007103820A1 (en) * 2006-03-02 2007-09-13 Altairnano, Inc. Nanostructured indium-doped iron oxide
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
US7964574B2 (en) 2006-08-04 2011-06-21 Baxter International Inc. Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
JP2010505882A (ja) * 2006-10-06 2010-02-25 バクスター・インターナショナル・インコーポレイテッド 表面改質微粒子を含むマイクロエンカプセルならびに、その形成および使用の方法
EP2077821B1 (en) 2006-10-12 2019-08-14 The University Of Queensland Compositions and methods for modulating immune responses
US20090169628A1 (en) 2006-10-17 2009-07-02 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials
US20080254258A1 (en) * 2007-04-12 2008-10-16 Altairnano, Inc. Teflon® replacements and related production methods
EP2146691A2 (en) * 2007-04-17 2010-01-27 Baxter International Inc. Nucleic acid microparticles for pulmonary delivery
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
MX2010011508A (es) 2008-04-18 2011-05-03 Baxter Int Composicion basada en microesferas para prevenir y/o revertir la nueva presentacion de diabetes autoinmune.
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
WO2010037021A2 (en) * 2008-09-29 2010-04-01 Armark Authentication Technologies, Llc Spinneret and method of spinning fiber
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
WO2010132763A1 (en) * 2009-05-15 2010-11-18 Armark Authentication Technologies, Llc Fiber having non-uniform composition and method for making same
EP2435092A2 (en) 2009-05-27 2012-04-04 Selecta Biosciences, Inc. Nanocarriers possessing components with different rates of release
EP2480596A1 (en) * 2009-09-25 2012-08-01 Armark Authentication Technologies, LLC Tissue fiber scaffold and method for making
ES2661978T3 (es) 2010-05-26 2018-04-04 Selecta Biosciences, Inc. Vacunas multivalentes de nanovehículos sintéticos
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique
EP2635596B8 (en) 2010-11-01 2020-03-11 University of Technology Sydney Immune-modulating agents and uses therefor
CN109172819A (zh) 2011-07-29 2019-01-11 西莱克塔生物科技公司 产生体液和细胞毒性t淋巴细胞（ctl）免疫应答的合成纳米载体
EP4198059A1 (en) 2014-05-27 2023-06-21 The University of Queensland Modulation of cellular stress
FR3067226B1 (fr) * 2017-06-13 2021-10-08 Rossignol Lange Element de chaussure de ski

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567650A (en) * 1969-02-14 1971-03-02 Ncr Co Method of making microscopic capsules
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
IN167096B (it) * 1985-04-04 1990-09-01 Akzo Nv
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
EP0366058A3 (en) * 1988-10-27 1991-03-20 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device

Also Published As

Publication number Publication date
IE912700A1 (en) 1992-02-12
CH682715A5 (fr) 1993-11-15
ITMI911953A1 (it) 1993-01-15
FI913646A0 (fi) 1991-07-31
ES2046083B1 (es) 1994-08-01
AU5939394A (en) 1994-06-02
DK141891D0 (da) 1991-07-31
AU649696B2 (en) 1994-06-02
KR920003962A (ko) 1992-03-27
SE505734C2 (sv) 1997-10-06
DE4125542A1 (de) 1992-02-06
IE65124B1 (en) 1995-10-04
IN178446B (it) 1997-05-03
CA2048270A1 (en) 1992-02-02
LU87982A1 (fr) 1992-04-15
SE9102249L (sv) 1992-02-02
NO300158B1 (no) 1997-04-21
GR910100330A (en) 1992-08-31
GB9016885D0 (en) 1990-09-12
FI913646A (fi) 1992-02-02
NZ238981A (en) 1992-11-25
GR1001512B (el) 1994-02-28
FI104149B1 (fi) 1999-11-30
NL194637B (nl) 2002-06-03
NO912986L (no) 1992-02-03
JP2818704B2 (ja) 1998-10-30
NL9101306A (nl) 1992-03-02
US5213812A (en) 1993-05-25
ES2046083A1 (es) 1994-01-16
IT1251788B (it) 1995-05-26
OA09387A (fr) 1992-09-15
DK141891A (da) 1992-02-02
MA22245A1 (fr) 1992-04-01
NO912986D0 (no) 1991-07-31
ATA152591A (de) 1993-01-15
CA2048270C (en) 1997-02-25
AU8146691A (en) 1992-02-06
FR2665360B1 (fr) 1995-02-10
AT396425B (de) 1993-09-27
NL194637C (nl) 2002-10-04
JPH05178740A (ja) 1993-07-20
ZA915565B (en) 1992-04-29
AU666808B2 (en) 1996-02-22
PT98497B (pt) 1997-10-31
HK33294A (en) 1994-04-22
FR2665360A1 (fr) 1992-02-07
PT98497A (pt) 1992-06-30
FI104149B (fi) 1999-11-30
MY107500A (en) 1995-12-30
TNSN91067A1 (fr) 1992-10-25
DK175756B1 (da) 2005-02-14
SE9102249D0 (sv) 1991-07-26
BE1004772A3 (fr) 1993-01-26

Similar Documents

Publication Publication Date Title
ITMI911953A0 (it) Procedimento di preparazione di composizione a cessione protratta e le composizioni cosi' ottenute
IT9021169A0 (it) "composizioni polioefiniche elastoplastiche"
NZ238545A (en) Dialkoxy-pyridinyl-benzimidazole derivatives; preparation and pharmaceutical compositions thereof
FR2640503B1 (fr) Compositions de ciments dentaires d'ionomere-verre
IL98508A0 (en) Water insoluble microencapsular pharmaceutical compositions and methods for the preparation thereof
ITMI950100A0 (it) Procedimento per la preparazione di composti ciclopentadienilici e composti cosi' ottenibili
ITTO920303A0 (it) "composizione farmaceutica antiinfiammatoria"
GB9001694D0 (en) Immunogenic compositions
IL98179A0 (en) Pharmaceutical compositions containing phenylpropanolamine
IT1269508B (it) Procedimento per la preparazione di particelle lavorate a secco, particelle lavorate a secco cosi' ottenute e composizioni farmaceutiche contenenti le particelle
NZ238177A (en) Nitrogen-containing-heterocyclic substituted 1,2-diazole derivatives; preparation thereof and fungicidal compositions
GB9011767D0 (en) Pharmaceutical compositions
NZ237442A (en) 1,6,7,9-tetrahydroxy-11-oxolabdane derivatives; their preparation and pharmaceutical compositions
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
IL99011A0 (en) 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them
IL98911A0 (en) 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them
NZ238848A (en) Sulphur-substituted mevinic acid compounds and pharmaceutical compositions
IT9021905A0 (it) Procedimento per la produzione di manufatti fosforescenti e manufatti cosi' ottenuti
GB9003185D0 (en) Pharmaceutical compositions
ITFI910242A1 (it) Procedimento per la formazione di calzature aperte e calzature cosi' costituite
IT8947738A0 (it) Procedimento per produrre poliesteralcoli e composizioni cosi' ottenuti
GB9015435D0 (en) Pharmaceutical compositions
FI991120A0 (fi) Vesiliukoisten peptidien pitkäaikaisesti vapautuvat koostumukset
IT9021212A0 (it) "procedimento per la preparazione di diarilalcani"
IT9021571A0 (it) Procedimento per l'ottenimento di additivi per composti cementizi ed additivi cosi' ottenuti

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970730